J:\wp\publish\newsletter\www\nlt992.pdf
ADVERSE REACTION NEWSLETTER 1999:2 This newsletter contains information reported toinformation reported does not necessarily reflectthe official views, decisions or policies of theInternational Drug Monitoring; however, the NATIONALLY CIRCULATED mainly associated with the dihydropyridine calcium channelblockers (CCBs) INFORMATION Brunet L, Miranda J, Farré M, Berini L, Mendieta C. G